Section III
1 – 10 of 5039
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Wild-goose chase, no predictable patient subgroups who benefit from meniscal surgery : patient-reported outcomes of 641 patients 1 year after surgery
-
Malignancies In Giant Cell Arteritis : A Population-Based Cohort Study
Stamatis, Pavlos LU
;
Turesson, Carl
LU
;
Willim, Minna
LU
;
Nilsson, Jan-Åke
LU
;
Englund, Martin
LU
and
Mohammad, Aladdin J
LU
(2020)
In Journal of Rheumatology
47(7).
p.400-406
Mark
- A novel semi-automatic hip morphology assessment tool is more accurate than manual radiographic evaluations
- Flaunting our assets. Making the most of the Nordic registry goldmine : Cerebral palsy as an example
- From contamination to infective endocarditis—a population-based retrospective study of Corynebacterium isolated from blood cultures
-
Educational inequalities in fracture-related mortality using multiple cause of death data in the Skåne region, Sweden
Lindéus, Maria LU ; Englund, Martin LU and Kiadaliri, Aliasghar A LU
(2020)
In Scandinavian Journal of Public Health
48(1).
p.72-79
Mark
- Rapid detection of antibiotic resistance in positive blood cultures by MALDI-TOF MS and an automated and optimized MBT-ASTRA protocol for Escherichia coli and Klebsiella pneumoniae
- Pathophysiology and management of sensitive skin : position paper from the special interest group on sensitive skin of the International Forum for the Study of Itch (IFSI)
-
Fasting reveals largely intact systemic lipid mobilization mechanisms in respiratory chain complex III deficient mice
Tomašić, Nikica LU ; Kotarsky, Heike LU ; de Oliveira Figueiredo, Rejane ; Hansson, Eva LU ; Mörgelin, Matthias LU ; Tomašić, Ivan ; Kallijärvi, Jukka LU ; Elmér, Eskil LU
;
Jauhiainen, Matti
and
Eklund, Erik A.
LU
, et al.
(2020)
In Biochimica et Biophysica Acta - Molecular Basis of Disease
1866(1).
Mark
- Increased risk of multiple myeloma in primary Sjögren's syndrome is limited to individuals with Ro/SSA and La/SSB autoantibodies